Export

EN
FR
Primaquine
Essential medicine status
Section:
6. Anti-infective medicines 6.5. Antiprotozoal medicines 6.5.3. Antimalarial medicines 6.5.3.1. Antimalarial medicines > Medicines for curative treatment
ATC codes: P01BA03
EMLc
Indication
Malaria due to Plasmodium vivax ICD11 code: 1F81
INN
Primaquine
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Additional notes
For use to reduce the transmission of Plasmodium falciparum and for radical cure of Plasmodium vivax and Plasmodium ovale infections.
Formulations
Oral > Solid > tablet: 7.5 mg (as phosphate) ; 15 mg (as phosphate)
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 2007 (TRS 946)
Changed in 2007 (TRS 950)
Changed in 2025 (TRS 1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Primaquine
DrugBank
Primaquine
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - to update the footnote with the listing for primaquine to specify use only for reducing the transmission of Plasmodium falciparum and to achieve radical cure of Plasmodium vivax and Plasmodium ovale infections.